Bioplus Life Sciences Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Bioplus Life Sciences Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $2.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Bioplus Life Sciences Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $2.0M Trade | TransData Nexus

Bioplus Life Sciences Private Limited

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $2.0M Total Trade · DGFT Verified

Bioplus Life Sciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.0M across 3 products in 1 therapeutic categories. Based on 41 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vitamin ($900.0K), Folic ($850.0K), Glucosamine ($300.0K).

Bioplus Life Sciences Private Limited — Export Portfolio & Destination Treemap

Bioplus Life Sciences Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Bioplus Life Sciences Private Limited? — Company Overview & Market Position

Bioplus Life Sciences Private Limited, established on March 19, 2004, is a private limited company headquartered in Bangalore, Karnataka, India. The company is registered under the Corporate Identification Number (CIN) U24232KA2004PTC033578. Its authorized capital stands at ₹36.35 crore, with a paid-up capital of ₹3.00 crore. The registered address is S.No.10-1A, Hoodi Village, Krishnarajapuram Hobli, Bangalore, Karnataka, India.

Bioplus Life Sciences specializes in the manufacturing and marketing of pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio encompasses nutritional supplements such as vitamins, folic acid, and glucosamine, catering to various therapeutic needs. As of March 31, 2022, Bioplus Life Sciences employed approximately 276 individuals, reflecting its commitment to quality and innovation in the pharmaceutical sector.

What Does Bioplus Life Sciences Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vitamin$900.0K 2

Product Portfolio — Top 3 by Export Value

Bioplus Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vitamin	Nutritional Supplements	$900.0K	18	0.6%	7
2	Folic	Nutritional Supplements	$850.0K	17	1.5%	7
3	Glucosamine	Nutritional Supplements	$300.0K	6	2.3%	9

Bioplus Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $2.0M. The top category is Nutritional Supplements (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Bioplus Life Sciences Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Bioplus Life Sciences operates manufacturing facilities in Bangalore, Karnataka, India. These facilities are equipped to produce a range of pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company emphasizes quality control and adheres to stringent manufacturing practices to ensure the safety and efficacy of its products. While specific production capacities are not publicly disclosed, the facilities are designed to meet both domestic and international demand.

3Key Leadership

The leadership team at Bioplus Life Sciences Private Limited includes:

Mr. Sundeep Aurora: Director, appointed on May 12, 2008.

Mr. Sunjeev Aurora: Director, appointed on May 12, 2008.

Ms. Neha Aurora: Additional Director, appointed on April 1, 2025.

The leadership team is responsible for steering the company's strategic direction and ensuring operational excellence in the pharmaceutical manufacturing sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Bioplus Life Sciences Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Bioplus Life Sciences Private Limited has made significant strides in expanding its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and certifications to market its pharmaceutical formulations in these regions. This includes compliance with Good Manufacturing Practices (GMP) and other regulatory standards set by authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and Therapeutic Goods Administration (TGA). These approvals underscore Bioplus's commitment to maintaining high-quality standards and meeting the stringent requirements of international markets.

2Emerging Markets

Bioplus Life Sciences Private Limited has strategically focused on penetrating emerging markets in Africa, Latin America, and Southeast Asia. The company has pursued World Health Organization (WHO) prequalification for its products, facilitating access to these regions. By obtaining WHO prequalification, Bioplus ensures that its pharmaceutical formulations meet international quality standards, thereby enhancing their acceptance and distribution in these emerging markets. This strategic approach enables the company to address the growing healthcare needs in these regions effectively.

Bioplus Life Sciences Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Bioplus Life Sciences Private Limited has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), enabling the export of its pharmaceutical formulations to the United States. The company has filed Abbreviated New Drug Applications (ANDAs) for its products, seeking approval for marketing in the U.S. market. Additionally, Bioplus has submitted Drug Master Files (DMFs) to the FDA, providing detailed information about the manufacturing processes and quality control measures of its products. The company maintains a history of successful FDA inspections, reflecting its adherence to stringent regulatory standards and commitment to product quality.

2WHO & EU GMP

Bioplus Life Sciences Private Limited has obtained World Health Organization (WHO) prequalification for its pharmaceutical formulations, affirming that its products meet international quality standards. The company has also secured European Union Good Manufacturing Practice (EU GMP) certificates, demonstrating compliance with the EU's stringent manufacturing and quality control requirements. These certifications enhance the company's credibility and facilitate the distribution of its products in global markets, including Europe and other regions recognizing WHO prequalification.

Bioplus Life Sciences Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Bioplus Life Sciences Private Limited operates in a competitive pharmaceutical market, facing competition from both domestic and international companies. Key competitors include established pharmaceutical manufacturers with a diverse product portfolio and a global presence. While specific market share data is not publicly disclosed, Bioplus's focus on high-quality pharmaceutical formulations and adherence to international regulatory standards position it as a competitive player in the industry. The company's strategic emphasis on both regulated and emerging markets further enhances its competitive edge.

2Key Differentiators

Bioplus Life Sciences Private Limited distinguishes itself through its commitment to quality, innovation, and regulatory compliance. The company's diverse product portfolio, including nutritional supplements and pharmaceutical formulations, caters to a wide range of therapeutic needs. Its strategic focus on obtaining international certifications, such as WHO prequalification and EU GMP, enhances its credibility and facilitates access to global markets. Additionally, Bioplus's emphasis on research and development enables it to introduce innovative products that meet evolving healthcare demands.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Bioplus Life Sciences Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Bioplus Life Sciences Private Limited has demonstrated a consistent track record in manufacturing and exporting pharmaceutical formulations. The company's export volume and consistency reflect its reliability as a supplier. Indicators of reliability include adherence to international quality standards, successful regulatory approvals, and a history of compliance with regulatory authorities. These factors collectively position Bioplus as a dependable partner in the pharmaceutical supply chain.

2Certifications to Verify

Importers should verify the following certifications when considering Bioplus Life Sciences Private Limited as a supplier:

FDA Facility Registration: Confirm the registration status of Bioplus's manufacturing facilities with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure that Bioplus's products are prequalified by the World Health Organization, indicating compliance with international manufacturing standards.

Frequently Asked Questions — Bioplus Life Sciences Private Limited

How many pharmaceutical products does Bioplus Life Sciences Private Limited export from India?

Bioplus Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Vitamin ($900.0K), Folic ($850.0K), Glucosamine ($300.0K). Total export value is $2.0M.

What is Bioplus Life Sciences Private Limited's total pharmaceutical export value?

Bioplus Life Sciences Private Limited's total pharmaceutical export value is $2.0M, based on 41 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Bioplus Life Sciences Private Limited cover?

Bioplus Life Sciences Private Limited exports across 1 therapeutic categories. The largest are Nutritional Supplements (100.0%, 3 products).

Get Full Bioplus Life Sciences Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.